Brief Educational Video for Patients Prescribed LTBI Treatment

Status Active, not recruiting

Clinical Trial Summary

Many patients who are prescribed treatment for latent tuberculosis (LTBI) do not complete treatment. Effective interventions that are low-cost and feasible for large-scale implementation are needed to support efforts to eliminate TB. The investigators hypothesize that a 3-minute educational LTBI video intervention will improve treatment completion compared to standard care (no intervention). A randomized trial will be conducted at Kaiser Permanente Southern California, including adults who are prescribed treatment for LTBI, identified using an electronic health record algorithm. At the time of treatment prescription, patients will be randomized to receive the LTBI video intervention or standard care at a ratio of 2 to 1. Those in the intervention group will be sent a secure text message or e-mail with a link to the video. Individuals who watch the LTBI video will be invited to respond to 4 short questions about their perceptions of the video accessibility and content. The primary outcome is LTBI treatment completion (dispensation of the required number of doses) in the year following prescription order. Secondary outcomes are LTBI treatment initiation (at least one dispensation) in the year following prescription order; initiation and completion within the year following prescription order stratified by LTBI treatment regimen (if feasible); the proportion of individuals randomized to the intervention group who watched the LTBI video; and the perceptions of those who watched the video. The primary analysis will be based on intention-to-treat. Characteristics of individuals in the intervention and standard care groups will be described, and rates of LTBI treatment completion will be calculated. To assess the effect of the intervention, Poisson regression with robust standard errors will be used to estimate unadjusted and adjusted rate ratios and 95% confidence intervals. Per-protocol analyses will also be conducted, comparing those in the intervention group who watched the LTBI video to those in the standard care group. Similar methods will be used for secondary analyses. Assuming the completion rate in the standard care group is 0.5 (based on recent KPSC data), approximately 918 patients will be needed to achieve 80% power with type one error 0.05 to detect an intervention effect of 0.10 in the completion rate between groups. This sample size will be feasible to achieve over the 1 year trial duration.

Clinical Trial Description

Please see the full protocol for details of the study. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05412212
Study type	Interventional
Source	Kaiser Permanente
Contact
Status	Active, not recruiting
Phase	N/A
Start date	June 3, 2022
Completion date	February 28, 2025

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05073926` - Rifampicin Resistance in S. Aureus During and After Treatment for Latent Tuberculosis
Not yet recruiting	`NCT04428294` - Impact of LTBI Treatment on Glucose Tolerance and Chronic Inflammation	Phase 4
Completed	`NCT02276755` - Vitamin D Supplementation in TB Prevention	Phase 3
Withdrawn	`NCT03498534` - Evaluation of Diabetes Control and Effect on Transmission and Development of Tuberculosis	Phase 4
Active, not recruiting	`NCT03988933` - 2R2: Higher Dose Rifampin for 2 Months vs Standard Dose Rifampin for Latent TB.	Phase 2
Recruiting	`NCT06022146` - TB YOUTH - TB sYstemic Management Using One-month, Ultra-short TPT Regimen for scHool Contacts	Phase 3
Active, not recruiting	`NCT04188041` - Improving Rhode Island's Tuberculosis Preventive Services in Primary Care	N/A
Recruiting	`NCT03730181` - Tuberculosis Clinical Trials Consortium Study 35	Phase 1/Phase 2
Completed	`NCT01967134` - Safety and Immunogenicity Study of AERAS-456 Vaccine for Tuberculosis	Phase 1
Completed	`NCT00257907` - Immune Response to Mycobacterium Tuberculosis Infection
Recruiting	`NCT05756582` - Prevalence of Latent Tuberculosis Infection in Health-care Workers and Students
Active, not recruiting	`NCT04557176` - TB Screening Improves Preventive Therapy Uptake	N/A
Completed	`NCT02119130` - Quantiferon Gold Test for Detecting Tuberculosis (TB) Infection in HIV/AIDS Patients in South Africa	N/A
Not yet recruiting	`NCT06281834` - Dolutegravir Pharmacokinetics During Weekly Rifapentine/Isoniazid for TB Prevention	Phase 1
Not yet recruiting	`NCT02512484` - Improving the Detection of Active Tuberculosis in Accident and Emergency Departments	N/A
Completed	`NCT00763295` - Is Tuberculin Skin Testing Effective in Screening for Latent Tuberculosis in Patients With HIV?	N/A
Completed	`NCT01850043` - The Epidemiology of TST Change in Korea	N/A
Completed	`NCT02073669` - Latent Tuberculosis in Second Generation Immigrants From High Risk Countries Compare to Low-risk Young Israeli Adults	N/A
Completed	`NCT02090374` - Development of Human Nasal Challenge Models With Microbial Constituents and Grass Pollen	N/A
Completed	`NCT02880982` - Trial of Vitamin D Supplementation in Cape Town Primary Schoolchildren	Phase 3